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Gaucher Disease: The N370S Mutation in Ashkenazi
Jewish and Spanish Patients has a Common Origin
and Arose Several Thousand Years Ago
To the Editor:
The identification of highly polymorphic markers, which
are widely distributed throughout the human genome,
has allowed the mapping of several disease genes. These
markers have been used to analyze the origin, in time
and place, of the most prevalent mutations for different
diseases, such as cystic fibrosis (Morral et al. 1994), idio-
pathic torsion dystonia (Risch et al. 1995), hereditary
colon cancer (Moisio et al. 1996), factor XI deficiency
(Peretz et al. 1997), and myotonic dystrophy (Tishkoff
et al. 1998). We present the analysis of the origin of
N370S, the most common Gaucher disease (GD) mu-
tation among Ashkenazi Jewish and Spanish patients.
The results show that both patient populations share the
same ancestral haplotype and that this mutation arose
several thousand years ago.
GD (MIM 230800), caused by mutations in the glu-
cocerebrosidase (GBA) gene, is the most prevalent ly-
sosomal storage disease. It is inherited as an autosomal
recessive trait, which is particularly frequent in the Ash-
kenazi Jewish population, with a disease incidence of
∼1/850 (Beutler and Grabowski 1995). It is also found
in other populations, albeit with lower frequency, with
a range of 1/40,000–1/60,000 (Grabowski 1993).
Among Ashkenazi Jewish patients with GD, ∼70% of
the alleles carry the N370S (1226ArG) mutation (Beu-
tler et al. 1992a; Horowitz et al. 1993; Sibille et al.
1993). It appears that approximately two-thirds of the
individuals homozygous for this mutation escape detec-
tion because of the very mild clinical manifestation; thus,
the N370S frequency in the Ashkenazi Jewish popula-
tion is higher, ∼90% of all GD mutations (Beutler et al.
1993; Grabowski 1997). This mutation is also frequent
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Table 1
Distances by RH and Meiotic Mapping between the GBA Gene and 1q21 Markers and
Estimated Age of the N370S Mutation
RH MAPPING MEIOTIC MAPPING
MARKER Distance (cR/va)
Age of the Mutation
(Years/Generations)b Distance (v)
Age of the Mutation
(Years /Generations)b
D1S305 45.0/.024 1,100/44 .023 1,300/52
D1S2140 39.4/.022 2,675/107 .0 )
D1S2777 19.8/.011 12,675/507 .0 )
D1S1595 43.8/.024 3,125/125 .0 )
D1S2721 55.0/.030 950/38 .0 )
D1S2624 67.2/.037 4,225/169 .025 9,525/381
a Obtained from the cR value, assuming 1 cR  50 kb and 900 kb  1 cM, and then by
use of Haldane map function.
b Age of the mutation estimated in number of generations, by use of the formula by Risch
et al. (1995). Years calculated assuming 25 years/generation.
in other populations of patients with GD, particularly
among Spanish patients, in whom it accounts for 1 40%
of the mutant alleles (Cormand et al. 1995, 1998).
We have recently mapped the GBA gene in relation
to several highly polymorphic markers (Cormand et al.
1997), which were then used to identify a putative an-
cestral haplotype associated with the N370S mutation
in chromosomes from Spanish patients (Cormand et al.
1998). Preliminary studies of a few Argentinian patients
with GD, of Ashkenazi Jewish origin, showed that they
have the same conserved haplotype as the Spanish pa-
tients with GD. This prompted us to perform the present
study on DNA isolated from 66 unrelated Ashkenazi
Jewish patients with GD of central and eastern European
descent living in the United States, who were evaluated
at the New York University Medical Center, and 14
Spanish patients with GD who were referred from dif-
ferent hospitals around Spain and enzymatically diag-
nosed at the Institut de Bioquı´mica Clı´nica in Barcelona.
Both groups of patients bore the N370S mutation. A
total of 104 N370S Ashkenazi Jewish chromosomes and
20 N370S Spanish chromosomes were analyzed. Forty
healthy Ashkenazi Jewish individuals from the United
States were used as controls, and CEPH family data were
used as non-Jewish controls. The distances (in terms of
recombination fractions [v]) between the markers used
for haplotyping and the GBA gene (Cormand et al.
1997) are shown in table 1. Linkage analysis between
the GBA gene and one of these markers, D1S1595, has
not been previously described (maximum LOD score of
9.33 at ). Since meiotic mapping showed insuf-v  .00
ficient resolution capacity for markers closest to the
GBA gene (D1S2140, D1S2777, D1S1595, and
D1S2721), the Stanford G3 radiation hybrid (RH) panel
(Research Genetics) was used to estimate the distances
between these markers and the GBA gene. Following
Cox et al. (1990) and Moisio et al. (1996), a 1 cR/50
kb ratio was used to calculate the distance in centimor-
gans (900 kb/1 cM), which we transformed into v values
using the Haldane map function. Hybrid DNA was am-
plified by PCR using standard protocols. Primers used
to detect the presence of the GBA gene were as follows:
forward, 5′-AACCATGATTCCCTATCTTC-3′; reverse,
5′-GAGGCACATCCTTAGAGGAG-3′. As noted by
Moisio et al. (1996), RH mapping generally yields
greater distances between marker loci than does meiotic
mapping.
Previously, we reported a common disease haplotype
in Spanish patients with GD bearing the N370S muta-
tion (Cormand et al. 1998). Analyses of 66 Ashkenazi
Jewish patients and five additional Spanish patients with
GD, using six microsatellite markers, revealed that most
of the Jewish and Spanish N370S chromosomes share
alleles for five of these markers. Figure 1a shows the
haplotype of the 73 Ashkenazi Jewish N370S chromo-
somes, of the 104 analyzed, for which the phase had
been established for all the markers (phases were deter-
mined by use of samples from parents and/or siblings).
Forty-three (59%) have a conserved haplotype for mark-
ers D1S2140, D1S2777, D1S1595, D1S2721, and
D1S2624. Marker D1S305 presented many different al-
leles and was not included in figure 1, to allow sample
grouping. If the more distant marker D1S2624 (see mei-
otic mapping, table 1) is excluded, the proportion of
chromosomes with a conserved haplotype rises to 68
(93%) of 73. If only the three markers closest to
GBA—D1S2140, D1S2777, and D1S1595, according
to RH mapping (see table 1)—are considered, this pro-
portion is increased to 69 (94.6%) of 73. The same
analysis of 18 Spanish N370S chromosomes for which
the phase is known, is shown in figure 1b. Two chro-
mosomes were excluded because phase could not be es-
tablished for all the markers. The haplotype for the three
closest markers mentioned above is conserved in 16
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Figure 1 Haplotype analysis for 1q21 markers. a, Chromosomes from Ashkenazi Jewish patients with GD bearing the N370S mutation.
b, Spanish patients with GD bearing the N370S mutation. Both groups were analyzed for markers D1S2140, D1S2777, D1S1595, D1S2721,
and D1S2624. The conserved parts of the haplotypes are boxed.
(88.9%) of 18 of the chromosomes. In addition, all Ash-
kenazi Jewish and Spanish N370S alleles bear the “”
allele for the HhaI site (data not shown), which corre-
sponds to an adenine at genomic position 6144, one of
the GBA internal polymorphisms (Beutler et al. 1992b).
Table 2 shows the allele frequencies and linkage dis-
equilibrium (LD) analysis for markers in chromosomes
bearing the N370S mutation in Ashkenazi Jewish and
Spanish patients and in the control population. The de-
gree of LD was assessed by the parameter d [d 
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Table 2
Haplotype and LD Analyses in N370S Chromosomes of Ashkenazi Jewish and Spanish Patients
MARKER ALLELE
FREQUENCY OF ASHKENAZI JEWISH CHROMOSOMES FREQUENCY OF SPANISH CHROMOSOMES
N370S Controls x2 (P value) d N370S Controlsa x2 (P value) d
D1S305 1 58.6 (41/70) 40.0 (32/80) 5.2 (P!.05) .31 47.4 (9/19) 23.2 (13/56) 4.0 (P!.05) .31
D1S2140 4 95.6 (86/90) 47.5 (38/80) 49.6 (P!.001) .92 90.0 (18/20) 30.4 (17/56) 21.1 (P!.001) .86
D1S2777 1 97.8 (89/91) 63.8 (51/80) 33.3 (P!.001) .94 90.0 (18/20) 57.1 (32/56) 7.1 (P!.01) .77
D1S1595 5 92.8 (77/83) 45.0 (36/80) 43.7 (P!.001) .87 90.0 (18/20) 28.2 (35/124) 28.3 (P!.001) .86
D1S2721 3 93.6 (88/94) 33.8 (27/80) 69.1 (P!.001) .90 70.0 (14/20) 23.1 (12/52) 13.8 (P!.001) .61
D1S2624 4 57.8 (52/90) 20.0 (16/80) 25.2 (P!.001) .47 20.0 (4/20) 17.9 (10/56) .05 (NS)b .03
a CEPH data.
b NS  not significant.
], in which pD is the frequency of the(p  p )/(1 p )D N N
associated allele on disease chromosomes and pN is the
frequency of the same allele on normal chromosomes,
as in the study by Risch et al. (1995), and statistical
significance was measured by the x2 test. All markers
were found to be in strong LD with the N370S mutation
in Ashkenazi Jewish patients ( ), except markerP ! .001
D1S305, for which the significance is very low (P !
). For the Spanish chromosomes, only the central.05
markers (D1S2140, D1S2777, D1S1595, andD1S2721)
are in marked LD with the N370S mutation. The fact
that the highest values of d, in both patient populations,
correspond to markers D1S2140, D1S2777, D1S1595,
and D1S2721, is consistent with meiotic mapping,
which places the GBA gene at a distance of (seev  .0
table 1). LD for the five markers (all except D1S305)
was confirmed in the Ashkenazi Jewish patients, with
the D′D/Dmax standardized coefficient (Lewontin1988)
and the likelihood ratio test described by Terwilliger
(1995) (data not shown), since this information was rel-
evant for the dating analysis.
To date the N370S mutation among the Ashkenazi
Jewish patients, we applied the following formula by
Risch et al. (1995):
log[(1Q)/(1 p )] log(d)Ng  7 ,
log(1 v) log(1 v)
in which g is the number of generations, Q is the prob-
ability that an N370S-bearing chromosome does not
carry a progenitor marker allele, and pN and d are as
described above. The estimation of the age of the mu-
tation is based on the calculated distance between the
gene of interest and the flanking markers. Marker
D1S2624 is the only one for which the distance to the
gene could be estimated by both meiotic and RH map-
ping (table 1), and it is in LD with the mutation (marker
D1S305 is not). Using these estimated distances for
marker D1S2624, we obtained a result of 381 or 169
generations, respectively, and, assuming 25 years/gen-
eration, an estimated age for the N370S mutation of
∼9,500 or 4,200 years, with an average of ∼7,000 years.
The values for the rest of the markers are shown in table
1.
To conclude, a similar haplotype was found to be as-
sociated with the common N370S mutation in the Span-
ish and Ashkenazi Jewish patients. This suggests a com-
mon origin for the mutation. The high frequency of
particular mutations among Ashkenazi Jews has been
explained either by a selective advantage of heterozygote
carriers or by a founder effect and genetic drift (Mo-
tulsky 1995; Peretz et al. 1997). Our data strongly sup-
port a founder effect as opposed to recurrence of the
N370S mutation: all the chromosomes with this muta-
tion had the “” allele for the GBA internal HhaI-site
polymorphism, and most of them share the alleles for
several markers close to the gene. The few exceptions
could be explained by historic recombinations.Although
a new occurrence of N370S cannot be ruled out, it seems
very unlikely. If we assume a founder effect, both genetic
drift and selective advantage could explain the expan-
sion of the mutated allele in the population. Our data
do not contribute to this discussion, which is beyond
the scope of the present work.
Several studies have attempted to date mutations for
diseases that are prevalent among the Ashkenazi Jews,
such as idiopathic torsion dystonia (Risch et al. 1995),
familial dysautonomia (Blumenfeld et al. 1993), Bloom
syndrome (Ellis et al. 1994), and factor XI deficiency
(Peretz et al. 1997). Whereas the dystonia mutation
seems to have occurred ∼300 years ago, one of the mu-
tations causing factor XI deficiency is supposed to be
quite old (12,000 years), as determined on the basis of
the shared haplotype found among Ashkenazi and Iraqi
Jews.
Our data provide information on the most frequent
mutation in GD, N370S, which occurred several thou-
sand years ago. It should be noted that the method of
dating the mutation is subject to statistical fluctuation
resulting from sampling variance and from uncertainty
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in the estimates of v (Risch et al. 1995); therefore any
accuracy beyond an estimation of several thousand years
for the age of the mutation is meaningless. However, the
relatively short length of the chromosomal region in
which LD is conserved strongly supports the idea of an
ancient origin for the N370S mutation.
The data presented here suggest a common origin for
this mutation in the Ashkenazi Jewish and Spanish pa-
tient populations. It could be speculated that the Spanish
N370S chromosomes derive from Jewish alleles, since
this mutation, very prevalent among Ashkenazi Jews, is
more frequent in Spain (Cormand et al. 1998) and Por-
tugal (Amaral et al. 1996) than in the rest of Europe
and since it is known that many Jews converted to Ca-
tholicism by the time of their expulsion from Spain in
the 15th century. Although Jewish individuals from the
Iberian Peninsula are believed to be of Sephardic origin,
the results of haplotype analysis for the Ashkenazi Jew-
ish chromosomes in our study suggest that the mutation
may have been introduced before the Ashkenazim and
Sephardim became relatively independent populations.
This event took place ∼800–1,000 years ago (Baron
1968; Ankori 1979), although contacts between the two
communities are known to have occurred after that time.
Against the hypothesis of a Jewish origin for the Span-
ish N370S chromosomes is the fact that overall LD val-
ues are lower among Spanish than among Ashkenazi
Jewish chromosomes (table 2). Because lower LD values
are indicative of a larger number of generations (Jorde
1995), our data support the hypothesis of an ancient
European, non-Jewish origin of the “Spanish”mutation.
Conversion of pagans to Judaism during the Roman pe-
riod could be an explanation for a possible way bywhich
the mutation could have entered the Jewish population.
The preliminary data presented recently by Dı´az et al.
(1998), showing that Ashkenazi Jewish N370S chro-
mosomes have higher LD values than those found in
Portuguese and French N370S chromosomes, are con-
sistent with the data presented here. The analysis of
N370S haplotypes in Sephardim and in other European
populations would be extremely useful, to clarify this
issue.
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Deafness Locus DFNB16 Is Located on Chromosome
15q13-q21 within a 5-cM Interval Flanked by
Markers D15S994 and D15S132
To the Editor:
Inherited human deafness has an incidence of ∼1/2,000
births (Cohen and Gorlin 1995). The hearing impair-
ment can be associated with other clinical features as
part of a distinct syndrome, but in most cases (70%) it
is the sole clinical sign (Bergstrom et al. 1971). Auto-
somal recessive transmission accounts for85%of non-
syndromic sensorineural deafness (Cohen and Gorlin
1995). Nonsyndromic autosomal recessive deafness is
clinically homogeneous; in most cases, the hearing loss
has a prelingual onset, involves all the frequencies, is
severe or profound, and is nonprogressive (Van Camp
et al. 1997). However, as expected from the structural
and functional complexity of the inner ear, sensorineural
deafness exhibits a very high genetic heterogeneity.Nine-
teen loci for autosomal recessive hearing loss have been
mapped, to date (Hereditary Hearing Loss home page).
One of these loci, DFNB16, wasmapped to chromosome
15q21-22 by linkage studies of three consanguineous
families from Pakistan, Palestine, and Syria (Campbell
et al. 1997). Analysis of recombinant haplotypes indi-
cated that the locus was in a 20-cM interval delimited
by markers D15S994 and D15S155. Acting on the re-
sults of homozygosity data, Campbell et al. (1997) nar-
rowed the location of DFNB16 to the 15-cM distal part
of the interval, between markers D15S1039 and
D15S155. The pedigree and haplotype analysis of family
S040 (fig. 1) provides evidence against the last conclu-
sion. Our work locates DFNB16 to the proximal 5-cM
part of the interval, between D15S1044 and D15S132.
Informed consent was obtained from all the individ-
uals included in the study. All the family members un-
derwent a clinical examination. Environmental factors
were eliminated as the cause of deafness in all affected
family members. There were no features suggestive of
ophthalmologic, skin, or renal syndromic anomalies.
Conductive hearing loss was ruled out by otoscopic ex-
amination, tympanometry with acoustic reflex testing,
and use of the tuning fork test. Pure-tone audiometry
was performed to test for air conduction (frequencies of
